Go Premium in Our Biggest Sale EverUPGRADE NOW
TipRanks
Go Ultimate75% OFF

Barry Greene Insider Profile

11 Followers

Barry Greene, Director at City Therapeutics, Inc., holds ― shares in City Therapeutics, Inc. (Ticker: CTY), holds 16.41K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 0.00 shares in SAGE Therapeutics (Ticker: SAGE).

Barry Greene's Trading History

KPTIKaryopharm Therapeutics		May 26, 2026DirectorUninformative Buy―$886.41
SAGESAGE Therapeutics		Jul 31, 2025―Uninformative Sell―$0.00
ALNYAlnylam Pharma		Sep 11, 2020PresidentUninformative Buy859.24K$11.46M
ACORQAcorda Therapeutics		May 23, 2018―Uninformative Buy25.66K$16.55
RGLSRegulus		Oct 11, 2012―Uninformative Buy―$50.19M
DYNDyne Therapeutics		―Director――
CTYCity Therapeutics, Inc.		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Barry Greene insider profile FAQ

What is the percentage of profitable transactions made by Barry Greene?
The percentage of profitable transactions made by Barry Greene is 0%.
What is the average return per transaction made by Barry Greene?
The average return per transaction made by Barry Greene is -38.10%.
What stocks does Barry Greene hold?
Barry Greene holds: CTY, ALNY, SAGE, DYN, KPTI, ACORQ, RGLS stocks.
What was Barry Greene's most profitable transaction?
Barry Greene’s most profitable transaction was an Informative Buy of SAGE stock on August 9, 2021. The return on the trade was -2.80%.
What is Barry Greene's role in City Therapeutics, Inc.?
Barry Greene's role in City Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.